26 / 72
[90]
Sroga GE, Vashishth D. UPLC methodology for identification and quantitation of
naturally fluorescent crosslinks in proteins: a study of bone collagen. J Chromatog B
Analyt Technol Biomed Life Sci 2011;879:379
–
85.
[91]
Paschalis EP, Mendelsohn R, Boskey AL. Infrared assessment of bone quality: a review.
Clin Orthop Relat Res 2011;469:2170
–
8.
[92]
Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the
femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int
2006;79:160
–
8.
[93]
Saito M, Fujii K, Soshi S, Tanaka T. Reductions in degree of mineralization and enzymatic
collagen cross-links and increases in glycation-induced pentosidine in the femoral neck
cortex in cases of femoral neck fracture. Osteoporos Int 2006;17:986
–
95.
[94]
Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos
Int 2006;17:319
–
36.
[95]
Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and
myocardial stiffening of aging and diabetes. J hypertens 2003;21:3
–
12.
[96]
Saito M, Marumo K, Fujii K, Ishioka N. Single-column high-performance liquid
chromatographic-fluorescence detection of immature, mature, and senescent cross-
links of collagen. Anal Biochem 1997;253:26
–
32.
[97]
Karim L, Tang SY, Sroga GE, Vashishth D. Differences in non-enzymatic glycation and
collagen cross-links between human cortical and cancellous bone. Osteoporos Int
2013;24:2441
–
7.
[98]
Karim L, Vashishth D. Heterogeneous glycation of cancellous bone and its association
with bone quality and fragility. PLoS ONE 2012;7:e35047.
[99]
Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced
cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats.
Osteoporos Int 2006;17:1514
–
23.
[100]
Knott L, Whitehead CC, Fleming RH, Bailey AJ. Biochemical changes in the collagenous
matrix of osteoporotic avian bone. Biochem J 1995;310:1045
–
51.
[101]
Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of
NF-kB pathwayactivation in neuroinflammation and oxidative stress. CNS Neurol Disord
Drug Targets 2014;13:1615
–
26.
[102]
Dong XN, Qin A, Xu J, Wang X. In situ accumulation of advanced glycation endproducts
(AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone
2011;49:174
–
83.
[103]
Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, et al. Development and
prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest
2001;108:261
–
8.
[104]
Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P. Pentosidine effects on human
osteoblasts in vitro. Ann NY Acad Sci 2008;1126:166
–
72.
[105]
Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al. Advanced glycation
end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic
pathways. Bone 2007;40:345
–
53.
[106]
Willett TL, Pasquale J, Grynpas MD. Collagen modifications in postmenopausal
osteoporosis: advanced glycation endproducts may affect bone volume, structure and
quality. Curr Osteoporos Rep 2014;12:329
–
37.
[107]
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation
in osteocalcin-deficient mice. Nature 1996;382:448
–
52.
[108]
Fantner GE, Oroudjev E, Schitter G, Golde LS, Thurner P, Finch MM, et al. Sacrificial bonds
and hidden length: unraveling molecular mesostructures in tough materials. Biophys J
2006;90:1411
–
8.
[109]
Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G. Changes of bone formation
markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women
with osteoporosis. Ann N Y Acad Sci 2009;1173(Suppl 1):E60
–
3.
[110]
Fodor D, Bondor C, Albu A, Simon SP, Craciun A, Muntean L. The value of osteopontin in
the assessment of bone mineral density status in postmenopausal women. J Invest Med
2013;61:15
–
21.
G. Osterhoff et al. / Injury, Int. J. Care Injured 47S2 (2016) S11
–
S20
S20